E-Mail
LUGANO, 6 May, 2021- The dermatological impact of COVID-19 is a burning topic at EADV s 2021 Spring Symposium. New research presented today highlights the effect that stringent hand hygiene during the pandemic has had on hand skin health.1
Researchers at Father Muller Medical College, India, analysed transepidermal water loss (TEWL - an essential parameter for measuring skin barrier function) from 582 people (291 healthcare professionals (HCPs) and 291 healthy individuals from the general population). Results indicated that hand dermatitis was now present among 92.6% of HCPs and 68.7% of the general population, despite only ~3% of HCPs and 2.4% of the general public in the study having reported a prior history of hand dermatitis (obtained through medical history and self-reported history). Higher mean TEWL (dryer skin) was also noted in females (65.4 g/m2h) and intensive care professionals (58.2 g/m2h), which was associated with high frequency of hand washing and use of a
E-Mail
LUGANO, 6 May, 2021- Researchers have discovered a novel biomarker to identify male COVID-19 patients most at risk for ICU admission. The findings presented today at EADV s 2021 Spring Symposium, suggest that men with genetic characteristics (phenotypes) sensitive to the male sex hormone androgen, are more likely to experience severe COVID-19 disease.
Researchers were driven to study the association between the androgen receptor (AR) gene and COVID-19, after observing the disproportionate number of men hospitalised with COVID-19 presenting with androgenetic alopecia (a common form of hair-loss) compared to the expected number in a similar age-matched population (79% vs. 31-53%).
Androgenetic alopecia is known to be controlled by variations in the AR gene, which affects how sensitive the body is to androgens (hormones such as testosterone). In addition, an enzyme implicated in COVID-19 infection (TMPRSS2) is regulated by an androgen response element - meaning that it too
E-Mail
LUGANO, 6 May, 2021- New research investigating for the first time the effects of modified intermittent fasting (MIF) on the skin of people with psoriasis has yielded promising results. Preliminary study findings presented today at the EADV Spring Symposium, show a significant reduction in scaling and thickness in patients with mild psoriasis after following a MIF 5:2 diet (eating normally for 5 days and restricting calorie intake on 2 non-consecutive days).
Psoriasis is a chronic, systemic immune-mediated inflammatory disease that causes raised plaques and scales on the skin s surface. The disease affects between 2-3% of the worlds adult population, and We had observed positive results in mice with gut inflammation and psoriasis, with inflammation in the gut driving cutaneous symptoms, shares Dr Lynda Grine, Postdoctoral Researcher, Department of Dermatology, Ghent University, Belgium Through scientific curiosity and my own experience with fasting as a Muslim, I wa